アジェンダ
9:00 AM — 5:00 PM
Course 1: PBRER9:00 AM — 5:00 PM
Course 2: Pharmacovigilance and Risk Management Planning7:15 AM — 8:15 AM
7:30 AM — 5:30 PM
8:15 AM — 8:30 AM
DIA Opening Remarks8:30 AM — 8:45 AM
Welcome Remarks9:30 AM — 11:00 AM
Session 1: FDA Updates11:00 AM — 11:30 AM
11:30 AM — 12:30 PM
Session 2: The New ICH12:30 PM — 2:00 PM
3:30 PM — 4:00 PM
4:00 PM — 5:30 PM
Session 4: Combination Products5:30 PM — 6:30 PM
6:30 PM — 9:00 PM
7:30 AM — 8:30 AM
7:30 AM — 6:00 PM
8:30 AM — 8:45 AM
Welcome Remarks9:30 AM — 11:00 AM
Session 5: EU Updates11:00 AM — 11:30 AM
11:30 AM — 12:45 PM
Session 6: Clinical Trial Issues12:45 PM — 2:00 PM
2:00 PM — 2:45 PM
Mid-Day Keynote2:45 PM — 4:15 PM
Session 7: Update on New Treatments4:15 PM — 4:45 PM
4:45 PM — 6:00 PM
Session 8: Advanced Therapeutics Pharmacovigilance and Risk Management7:00 AM — 8:00 AM
7:00 AM — 3:00 PM
8:00 AM — 8:15 AM
Welcome Remarks9:00 AM — 10:00 AM
Session 9: Advanced Technologies10:00 AM — 10:45 AM
10:45 AM — 12:15 PM
Session 10: Regional Updates12:15 PM — 12:30 PM
12:30 PM — 1:45 PM
1:45 PM — 3:15 PM
Session 11: Hot Topics3:15 PM — 3:30 PM
Closing Remarks